期刊
NEUROSCIENCE LETTERS
卷 649, 期 -, 页码 164-169出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2016.11.061
关键词
Posttraumatic stress disorder; Stress; Neuropeptides; Neuropeptide Y; Resilience; Therapeutics
资金
- Avanir Pharmaceuticals
Resilience to traumatic stress is a complex psychobiological process that protects individuals from developing posttraumatic stress disorder (PTSD) or other untoward consequences of exposure to extreme stress, including depression. Progress in translational research points toward the neuropeptide Y (NPY) system - among others - as a key mediator of stress response and as a potential therapeutic focus for PTSD. Substantial preclinical evidence supports the role of NPY in the modulation of stress response and in the regulation of anxiety in animal models. Clinical studies testing the safety and efficacy of modulating the NPY system in humans, however, have lagged behind. In the current article, we review the evidence base for targeting the NPY system as a therapeutic approach in PTSD, and consider impediments and potential solutions to therapeutic development. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据